DataMEDS AI, Inc. (MEDS) Profit Margins
Over the twelve months to 2026-06-30, DataMEDS AI, Inc. (MEDS) had gross margin -90.6%, operating margin -875.7%, net margin -1100.3%, free cash flow margin -182.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MEDSDataMEDS AI, Inc.Follow MEDS — free
—
Price chart with a free account
- Market cap
- 6.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Gross margin | 9.7% | -27.5% | -90.6% | |
| Operating margin | -33.9% | -401.7% | -875.7% | |
| Net margin | -37.8% | -433.9% | -1100.3% | |
| FCF margin | -8.8% | -50.3% | -182.7% |
USD millions · SEC XBRL
DataMEDS AI, Inc. — questions
- What is DataMEDS AI, Inc.'s gross margin?
- -90.6% over the twelve months to 2026-06-30.
- What is DataMEDS AI, Inc.'s operating margin?
- -875.7% over the twelve months to 2026-06-30.
- What is DataMEDS AI, Inc.'s net profit margin?
- -1100.3% over the twelve months to 2026-06-30.
Every figure on this page comes from DataMEDS AI, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.